BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

312 related articles for article (PubMed ID: 21102580)

  • 1. The role of microRNAs in liver cancer progression.
    Huang S; He X
    Br J Cancer; 2011 Jan; 104(2):235-40. PubMed ID: 21102580
    [TBL] [Abstract][Full Text] [Related]  

  • 2. miRNAs affect the development of hepatocellular carcinoma via dysregulation of their biogenesis and expression.
    Chu R; Mo G; Duan Z; Huang M; Chang J; Li X; Liu P
    Cell Commun Signal; 2014 Jul; 12():45. PubMed ID: 25012758
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Identification of invasion-metastasis-associated microRNAs in hepatocellular carcinoma based on bioinformatic analysis and experimental validation.
    Lou W; Chen J; Ding B; Chen D; Zheng H; Jiang D; Xu L; Bao C; Cao G; Fan W
    J Transl Med; 2018 Sep; 16(1):266. PubMed ID: 30268144
    [TBL] [Abstract][Full Text] [Related]  

  • 4. MicroRNAs and liver cancer associated with iron overload: therapeutic targets unravelled.
    Greene CM; Varley RB; Lawless MW
    World J Gastroenterol; 2013 Aug; 19(32):5212-26. PubMed ID: 23983424
    [TBL] [Abstract][Full Text] [Related]  

  • 5. MicroRNAs in hepatocellular carcinoma: regulation, function, and clinical implications.
    Sun J; Lu H; Wang X; Jin H
    ScientificWorldJournal; 2013; 2013():924206. PubMed ID: 23431261
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Small but Heavy Role: MicroRNAs in Hepatocellular Carcinoma Progression.
    Chen E; Xu X; Liu R; Liu T
    Biomed Res Int; 2018; 2018():6784607. PubMed ID: 29951542
    [TBL] [Abstract][Full Text] [Related]  

  • 7. MicroRNAs involved with hepatocellular carcinoma (Review).
    Mao B; Wang G
    Oncol Rep; 2015 Dec; 34(6):2811-20. PubMed ID: 26398882
    [TBL] [Abstract][Full Text] [Related]  

  • 8. MicroRNA-9 reduces cell invasion and E-cadherin secretion in SK-Hep-1 cell.
    Tan HX; Wang Q; Chen LZ; Huang XH; Chen JS; Fu XH; Cao LQ; Chen XL; Li W; Zhang LJ
    Med Oncol; 2010 Sep; 27(3):654-60. PubMed ID: 19572217
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The role and clinical implications of microRNAs in hepatocellular carcinoma.
    Zhao X; Yang Z; Li G; Li D; Zhao Y; Wu Y; Robson SC; He L; Xu Y; Miao R; Zhao H
    Sci China Life Sci; 2012 Oct; 55(10):906-19. PubMed ID: 23108868
    [TBL] [Abstract][Full Text] [Related]  

  • 10. MicroRNA-519c-3p promotes tumor growth and metastasis of hepatocellular carcinoma by targeting BTG3.
    Wang L; Mo H; Jiang Y; Wang Y; Sun L; Yao B; Chen T; Liu R; Li Q; Liu Q; Yin G
    Biomed Pharmacother; 2019 Oct; 118():109267. PubMed ID: 31387005
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Role of microRNAs in hepatocellular carcinoma.
    Liu LN; Li DD; Xu HX; Zheng SG; Zhang XP
    Front Biosci (Landmark Ed); 2015 Jun; 20(7):1056-67. PubMed ID: 25961544
    [TBL] [Abstract][Full Text] [Related]  

  • 12. MicroRNA-375 targets AEG-1 in hepatocellular carcinoma and suppresses liver cancer cell growth in vitro and in vivo.
    He XX; Chang Y; Meng FY; Wang MY; Xie QH; Tang F; Li PY; Song YH; Lin JS
    Oncogene; 2012 Jul; 31(28):3357-69. PubMed ID: 22056881
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Research progress of miRNAs targeting GSK-3β in regulation of hepatocellular carcinoma invasion and metastasis].
    He SQ; Wen B; Chen GX; Sun HT; Sun JL; Yang XM
    Nan Fang Yi Ke Da Xue Xue Bao; 2017 Jan; 37(1):138-140. PubMed ID: 28109115
    [TBL] [Abstract][Full Text] [Related]  

  • 14. miR-383 inhibits hepatocellular carcinoma cell proliferation via targeting APRIL.
    Chen L; Guan H; Gu C; Cao Y; Shao J; Wang F
    Tumour Biol; 2016 Feb; 37(2):2497-507. PubMed ID: 26385772
    [TBL] [Abstract][Full Text] [Related]  

  • 15. MiR-942-3p Promotes the Proliferation and Invasion of Hepatocellular Carcinoma Cells by Targeting MBL2.
    Xu CY; Dong JF; Chen ZQ; Ding GS; Fu ZR
    Cancer Control; 2019; 26(1):1073274819846593. PubMed ID: 31046434
    [TBL] [Abstract][Full Text] [Related]  

  • 16. MicroRNA-101 inhibits human hepatocellular carcinoma progression through EZH2 downregulation and increased cytostatic drug sensitivity.
    Xu L; Beckebaum S; Iacob S; Wu G; Kaiser GM; Radtke A; Liu C; Kabar I; Schmidt HH; Zhang X; Lu M; Cicinnati VR
    J Hepatol; 2014 Mar; 60(3):590-8. PubMed ID: 24211739
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Long non-coding RNA PTTG3P functions as an oncogene by sponging miR-383 and up-regulating CCND1 and PARP2 in hepatocellular carcinoma.
    Zhou Q; Zhang W; Wang Z; Liu S
    BMC Cancer; 2019 Jul; 19(1):731. PubMed ID: 31340767
    [TBL] [Abstract][Full Text] [Related]  

  • 18. microRNA involvement in hepatocellular carcinoma.
    Negrini M; Gramantieri L; Sabbioni S; Croce CM
    Anticancer Agents Med Chem; 2011 Jul; 11(6):500-21. PubMed ID: 21554203
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of miR-339-5p on invasion and prognosis of hepatocellular carcinoma.
    Wang YL; Chen CM; Wang XM; Wang L
    Clin Res Hepatol Gastroenterol; 2016 Feb; 40(1):51-6. PubMed ID: 26186881
    [TBL] [Abstract][Full Text] [Related]  

  • 20. MicroRNA-188-5p suppresses tumor cell proliferation and metastasis by directly targeting FGF5 in hepatocellular carcinoma.
    Fang F; Chang RM; Yu L; Lei X; Xiao S; Yang H; Yang LY
    J Hepatol; 2015 Oct; 63(4):874-85. PubMed ID: 25998163
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.